Revvity Inc
(NYSE:RVTY)
$
116.14
-0.09 (-0.08%)
Market Cap: 14.13 Bil
Enterprise Value: 16.22 Bil
PE Ratio: 56.19
PB Ratio: 1.79
GF Score: 81/100 Revvity Inc at Evercore ISI HealthCONx Conference Transcript
Nov 28, 2023 / 02:10PM GMT
Release Date Price:
$87.75
(-0.57%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
I'm Vijay Kumar, the life science tools and med-tech analyst at Evercore. A pleasure to have with us Revvity. Representing the company, we have CEO, Prahlad Singh. And we also have Steve Willoughby in the audience. Steve was shy, he didn't want to come up on stage, but we will let Steve relax for a few minutes there.
Prahlad, maybe tools -- there has never been a dull moment for life science tools this year. Pretty remarkable '23 for a variety of reasons. But before we get into some of the macro issues, for you guys, you've had like a tremendous portfolio transformation, right?
Questions & Answers
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Just at a high level, give us a big picture view on how Revvity has changed over the past few
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot